Illinois is experiencing both an opioid overdose epidemic and the COVID-19 pandemic. The numbers of fatal opioid overdoses have increased since 2019 with treatment and harm reduction services complicated by the ongoing COVID-19 pandemic. The goal of this publication is to provide a brief update on the state of the opioid epidemic in Illinois during the COVID-19 pandemic. The 2020 fatality data are provisional, and numbers may change as cases are reviewed and only available through the third quarter of 2020.
A PDF of this report :
Illinois Opioid Overdose Epidemic during the Covid-19 Pandemic
A link to the IDPH website for this report and more information is here
SEOW Members Crystal Reinhart, Doug Smith and others in the School of Social Work at UIUC recently published an article on youth opioid use based on data from the Illinois Youth Survey. Here is the citation and the abstract:
Barton, A., Reinhart, C.A., Campbell, C., Smith, D.C., & Albarracin, D. (2020). Opioid use at the transition to emerging adulthood: A latent class analysis of non-medical use of prescription opioids and heroin use. Addictive Behaviors, 114. doi: 10.1016/j.addbeh.2020.106757
Background: Although rates of nonmedical opioid use are highest in late adolescence and emerging adulthood, efforts to understand the extent of the heterogeneity in opioid misuse during this time have been limited. The current study aimed to derive and define typologies of opioid use in high school students at the onset of emerging adulthood.
Methods: Survey responses from a statewide sample of high school students aged 18 and 19 (N = 26,223) were analyzed. Group-based comparisons between participants reporting opioid use and those not reporting opioid use
were conducted. Among those reporting opioid use (n = 1,636), we conducted a latent class analysis (LCA) to identify heterogeneous subgroups of opioid users on the basis of non-medical use of prescription opioids (NMUPO) and heroin use. The resulting classes were then compared across various risk and protective factors using multinominal logistic regression.
Results: Consistent differences were observed between participants using opioids and participants not using opioids, with moderate to large effect sizes. Results from LCA revealed three subclasses: NMUPO-Any Use, NMUPO To Get High, and Heroin Use. Subclass differences were observed for non-opioid substance use, mental health, and demographics.
Conclusions: Findings from this study underscore the variability of youth who engage in opioid use in late adolescence. Results also indicate that opioid use during adolescence is likely indicative of a broader set of substance use and mental health issues.
This is to announce that the 2019 Illinois Pregnancy Risk Assessment Monitoring System (PRAMS) detailed data tables were just posted to the IDPH website. This is the fourth year of data collection using the Phase 8 version of the PRAMS survey.
The 2019 results are available by clicking the green “Select a year” button in the middle of the page available at http://dph.illinois.gov/data-statistics/prams. On the 2019 results landing page, a comprehensive set of charts is provided in the “2019 Illinois PRAMS Detailed Data Tables” link. There also are chart-specific hyperlinks allowing you to see the available charts and to view them individually.
Opioid supplement data collected from April 2019 through December 2019 are included in the results beginning on Table 81. These results replace the opioid results released earlier this year for the period April 2019 through August 2019.
As always, I am interested in your feedback on the data tables. I also am interested in knowing if you use the PRAMS data for education purposes, or for program or policy development that could be highlighted in a Data to Action report to the CDC. Please feel free to e-mail or call with your comments and feedback.
Thank you for your support of the PRAMS program!
Julie B. Doetsch, M.A.
Perinatal Health Data Manager
Illinois Department of Public Health
525 W. Jefferson St., 2nd Floor
Springfield, IL 62701
217-785-1064 ext. 5
Schedule: M-Th 7:30a–4:30p, Alternating Fridays 7:30a-3:00p / Off
The Center for Disease Control and Prevention published a study outlining that prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%–22% of women filled a prescription for opioids during pregnancy; however, data on self-reported prescription opioid use during pregnancy are limited.
Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019